Cargando…

Development and Validation of a Dissolution Test for Meloxicam and Pridinol Mesylate from Combined Tablet Formulation

The association of meloxicam and pridinol is indicated for treating muscular contractures and low back pain. A dissolution test for the meloxicam-pridinol combined tablet formulation was developed and validated, using a suitable HPLC method for simultaneously quantitating both dissolved drugs. The o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vignaduzzo, S. E., Castellano, P. M., Kaufman, T. S.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929778/ https://www.ncbi.nlm.nih.gov/pubmed/20838523 http://dx.doi.org/10.4103/0250-474X.65033

Ejemplares similares

Validation of Simultaneous Volumetric and HPLC Methods for the Determination of Pridinol Mesylate in Raw Material
por: Simionato, Laura D., et al.
Publicado: (2013)

Development and Validation of Discriminating and Biorelevant Dissolution Test for Lornoxicam Tablets
por: Anumolu, P. D., et al.
Publicado: (2015)

Dissolution Kinetics of Meloxicam Formulations Co-Milled with Sodium Lauryl Sulfate
por: Patera, Jan, et al.
Publicado: (2022)

Development and Validation of New Discriminative Dissolution Method for Carvedilol Tablets
por: Raju, V., et al.
Publicado: (2011)

Formulation development of chewable albendazole tablets with improved dissolution rate
por: Kimaro, Emmanuel, et al.
Publicado: (2019)

Comparison between the dissolution profiles of nine meloxicam tablet brands commercially available in Buenos Aires, Argentina
por: Simionato, Laura D., et al.
Publicado: (2018)

Smartcrystals for Efficient Dissolution of Poorly Water-Soluble Meloxicam
por: Ambrus, Rita, et al.
Publicado: (2022)

Natural Polymer Chitosan as Super Disintegrant in Fast Orally Disintegrating Meloxicam Tablets: Formulation and Evaluation
por: Draksiene, Gailute, et al.
Publicado: (2021)

Formulation and In Vitro, In Vivo Evaluation of Effervescent Floating Sustained-Release Imatinib Mesylate Tablet
por: Kadivar, Ali, et al.
Publicado: (2015)

Pharmacokinetics of oral pridinol: Results of a randomized, crossover bioequivalence trial in healthy subjects
por: Richter, Maren, et al.
Publicado: (2021)

Formulation Development of Albendazole-Loaded Self-Microemulsifying Chewable Tablets to Enhance Dissolution and Bioavailability
por: Sawatdee, Somchai, et al.
Publicado: (2019)

In Vivo Relevance of a Biphasic In Vitro Dissolution Test for the Immediate Release Tablet Formulations of Lamotrigine
por: Incecayir, Tuba, et al.
Publicado: (2023)

The Effect of Humidity on the Dissolution Kinetics and Tablet Properties of Immediate-Release Tablet Formulation Containing Lamotrigine
por: Lalić-Popović, Mladena, et al.
Publicado: (2022)

Comparison of Dissolution Profiles and Serum Concentrations of Two Lamotrigine Tablet Formulations
por: Lalic, Mladena, et al.
Publicado: (2012)

Correction: Formulation and In Vitro, In Vivo Evaluation of Effervescent Floating Sustained-Release Imatinib Mesylate Tablet
Publicado: (2022)

Fabrication and In-vitro Evaluation of Buccal Mucoadhesive Tablet of Meloxicam
por: Arabi, Mahshid, et al.
Publicado: (2020)

Determination of Doxazosin Mesylate in Tablets by RP-HPLC
por: Dhanya, B., et al.
Publicado: (2011)

Two Validated Spectrofluorometric Methods for Determination of Gemifloxacin Mesylate in Tablets and Human Plasma
por: Atia, Noha N., et al.
Publicado: (2013)

Validation of assay indicating method development of meloxicam in bulk and some of its tablet dosage forms by RP-HPLC
por: Sahoo, Nalini Kanta, et al.
Publicado: (2014)

In Vitro Dissolution Profile of Dapagliflozin: Development, Method Validation, and Analysis of Commercial Tablets
por: de Meira, Rafaela Zielinski Cavalheiro, et al.
Publicado: (2017)

Physicochemical Characterization and Dissolution Properties of Meloxicam-Gelucire 50/13 Binary Systems
por: El-Badry, Mahmoud
Publicado: (2011)

Psyllium (Plantago Ovata Forsk) Husk Powder as a Natural Superdisintegrant for Orodispersible Formulations: A Study on Meloxicam Tablets
por: Draksiene, Gailute, et al.
Publicado: (2019)

Apatinib mesylate tablet in the treatment of advanced malignant melanoma
por: Yang, Lingge, et al.
Publicado: (2018)

Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug
por: Patel, D. S., et al.
Publicado: (2015)

Development and Validation of Discriminative Dissolution Method for Metformin Immediate-Release Film-Coated Tablets
por: Mitrevska, Ivana, et al.
Publicado: (2019)

Dissolution of Pentoxifylline from Extended Release Formulations. Researches Concerning Development of a Biorelevant Test
por: Ionica, Georgeta, et al.
Publicado: (2009)

Potential of flow injection analysis for dissolution tests: application to on-line monitoring of tablets with different dissolution rates
por: Cosano, J. S., et al.
Publicado: (1990)

Meloxicam emulgels for topical management of rheumatism: Formulation development, in vitro and in vivo characterization
por: Mwangi, Alex N., et al.
Publicado: (2021)

Development and Validation of a UV Spectrophotometric Method for the Simultaneous Estimation of Eprosartan Mesylate and Hydrochlorothiazide in Bulk and Formulations
por: Anandakumar, K., et al.
Publicado: (2011)

Development of Abiraterone Acetate Nanocrystal Tablets to Enhance Oral Bioavailability: Formulation Optimization, Characterization, In Vitro Dissolution and Pharmacokinetic Evaluation
por: Liu, Yuanfen, et al.
Publicado: (2022)

Formulation Development and Dissolution Rate Enhancement of Efavirenz by Solid Dispersion Systems
por: Koh, P. T., et al.
Publicado: (2013)

Influence of the Efavirenz Micronization on Tableting and Dissolution
por: Pinto, Eduardo Costa, et al.
Publicado: (2012)

The Effect of an Optimized Wet Milling Technology on the Crystallinity, Morphology and Dissolution Properties of Micro- and Nanonized Meloxicam
por: Bartos, Csilla, et al.
Publicado: (2016)

Effects of temperature and wavelength choice on in-situ dissolution test of Cimetidine tablets
por: Li, Xin-Xia, et al.
Publicado: (2013)

Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine Tablets
por: Carapeto, Gustavo Vaiano, et al.
Publicado: (2023)

First-Principles and Empirical Approaches to Predicting In Vitro Dissolution for Pharmaceutical Formulation and Process Development and for Product Release Testing
por: Zaborenko, Nikolay, et al.
Publicado: (2019)

Topical Delivery of Meloxicam using Liposome and Microemulsion Formulation Approaches
por: Zhang, Julia, et al.
Publicado: (2020)

Automatic Dissolution Testing with High-Temporal Resolution for Both Immediate-Release and Fixed-Combination Drug Tablets
por: Chi, Zhongmei, et al.
Publicado: (2019)

Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability
por: Rahim, Haroon, et al.
Publicado: (2020)

Development of Nafamostat Mesylate Immediate-Release Tablet by Drug Repositioning Using Quality-by-Design Approach
por: Kim, Hyeon-A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tvkegcu5e9cjv16ubpn73oeqqc